Lactorel
Lactorel is an oral treatment for Fabry disease. It is a pharmacological chaperone indicated for the long-term treatment of adolescent and adult patients with confirmed diagnosis of Fabry disease (α-galactosidase A deficiency) who are carriers of mutations and may have a treatment response.
Therapeutic Area
Rare Diseases
Active Ingredient
Migalastat
Line
Rare Diseases
Dosage Forms
123 mg x 14 hard capsules.
